Tivic Health Systems, Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus pain, pressure, and congestion. The company sells its products on online retailers, commercial distributors, and through its own websites; The company's lead product include Entolimo, a biologic program focuses on immunotherapeutics is the late-stage TLR5 agonist for the treatment of acute radiation syndrome. In addition, it markets commercial product under the brand name ClearUP Sinus Pain Relief. It also focusses on non-invasive vagus nerve stimulation. The company was incorporated in 2016 and is headquartered in Fremont, California.